Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Justin Stebbing and Silvia Ottaviani.
Justin Stebbing
Connection Strength
1.672
Silvia Ottaviani
  1. What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials. Med (N Y). 2020 Dec 18; 1(1):9-10.
    View in: PubMed
    Score: 0.883
  2. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
    View in: PubMed
    Score: 0.230
  3. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):107-111.
    View in: PubMed
    Score: 0.226
  4. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697.
    View in: PubMed
    Score: 0.222
  5. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert Opin Drug Saf. 2020 Nov; 19(11):1505-1511.
    View in: PubMed
    Score: 0.056
  6. CNS penetration of potential anti-COVID-19 drugs. J Neurol. 2020 Jul; 267(7):1880-1882.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.